Skip to content

The effect of aleo vera cream on vaginal atrophy

To compare the effect of estrogen, aloevera vaginal cream on urogenital symptoms of post menopausal women randomized triple blind controled clinical trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190405043170N1
Enrollment
50
Registered
2019-10-01
Start date
2019-04-30
Completion date
Unknown
Last updated
2019-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post menopausal atrophic vaginitis. Postmenopausal atrophic vaginitis

Interventions

Intervention 1: Control group : Estrogen cream
using every day in first 10 days then 3 days in week till 6 weeks. Intervention 2: Intervention group : Aloe vera cream
using every day in first 10 days then 3 days in week till 6 weeks.

Sponsors

Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
40 Years to No maximum

Inclusion criteria

Inclusion criteria: non hysterectomized postmenopausal with 2 or more years since final menstrual cycle age > 40 years with urogenital symptoms ( vaginal dryness, pruritus,dyspareunia, burning and dysuria ) .

Exclusion criteria

Exclusion criteria: USING EXOGENOUS SEX HORMONE DURING 6 MONTHS BEFORE STARTING STUDY RECENT CORTICOSTEROID USE VAGINAL INFECTION VAGINAL ABNORMALITY VAGINAL BLEEDING WITH UNKNOWN ORIGIN KNOWN OR SUSPECTED HISTORY OF HORMONE DEPENDENT TUMOR BREAST CARCINOMA ACUTE THROMBOEMBOLIC DISORDER ASSOCIATED WITH ESTROGEN USE ANY SERIOUS DISEASE OR CHRONIC CONDITION SUCH AS HEPATIC DISORDER OR MODERATE TO SEVERE HTN THAT INTERFERE WITH STUDY COMPLIANCE

Design outcomes

Primary

MeasureTime frame
Rate of treatment satisfaction using 5-point Likert scale. Timepoint: 6 weeks after cream administration. Method of measurement: Subjectively using 5-point Likert scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactLida Ghaedian

Shiraz University of Medical Sciences

ghaedianm@sums.ac.ir+98 71 3233 2365

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026